New Covid vaccines are coming to the U.S. this fall, but uptake may be low — Here’s why
Pfizer, Moderna and Novavax are slated to deliver new single-strain Covid shots targeting the omicron subvariant XBB.1.5 in September. Source
Read MorePfizer, Moderna and Novavax are slated to deliver new single-strain Covid shots targeting the omicron subvariant XBB.1.5 in September. Source
Read MoreInvestors are wrapping up what's set to be a third straight winning week for the S&P 500 and the Dow
Read MoreTake a look at the stocks Morgan Stanley said could rise on positive tailwinds this earnings season. Source link
Read MorePfizer is among several drugmakers racing to develop the world's first shot targeting Group B strep disease, which kills thousands
Read MoreSome new selling opportunities are beginning to surface as stocks hit rally mode, including this telecommunications stocks stock. Source link
Read MoreThe HHS program aims to maintain broad access to Covid shots and treatments after the federal government shifts those products
Read MoreThese stocks are the most overbought and oversold on Wall Street. Source link
Read MoreThe DOJ said the former employee and his close friend sold their Pfizer call options at "significant profits" totaling more
Read MoreFor now, Eli Lilly's orforglipron appears to be the top contender in the weight loss pill space due to its
Read More